Mepacrine pigmentation in systemic lupus erythematosus.
- 1 August 1979
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 101 (2) , 147-153
- https://doi.org/10.1111/j.1365-2133.1979.tb05599.x
Abstract
A case of mepacrine [antimalarial therapeutic] pigmentation occurring in a patient with systemic lupus erythematosus was investigated by fluorescent light microscopy, GLC and analytical EM. There is strong evidence for the presence of mepacrine itself within the typical granules, which was shown by EM to be membrane bound and intracellular. Analytical EM also showed that the granules contain large quantities of Fe and smaller quantities of S.This publication has 14 references indexed in Scilit:
- Pigmentation From Antimalarial TherapyArchives of Dermatology, 1963
- Chloroquine Macular DegenerationArchives of Ophthalmology (1950), 1962
- Ocular Reactions to Antimalarial DrugsArchives of Dermatology, 1961
- Visual Disturbances with Antimalarial Drugs, with Particular Reference to Chloroquine KeratopathyArchives of Dermatology, 1959
- THE OCULAR COMPLICATIONS OF CHLOROQUINE THERAPYThe Lancet, 1958
- The Effects of Atabrine on the Human Visual System*American Journal of Ophthalmology, 1946
- UNUSUAL PIGMENTATION DEVELOPING AFTER PROLONGED SUPPRESSIVE THERAPY WITH QUINACRINE HYDROCHLORIDEArchives of Dermatology, 1946
- Primary Degradation Products of Mepacrine in Human UrinesNature, 1945
- Pigmentation of the Palate and Subungual Tissues Associated with Suppressive Quinacrine Hydrochloride TherapyThe American Journal of Tropical Medicine and Hygiene, 1945
- Pigmentation of the SkinNew England Journal of Medicine, 1944